Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

NMDA receptors, 50-51

In addition to being expressed in neurons, NMDA receptors are expressed as well in growth cones of oligodendrocytes, and play a critical role both in development and in ischemia-induced damage (Karadottir et al., 2005 Salter and Fern, 2005). [Pg.45]

Molecular composition NMDA receptors are composed of multiple subunits including at least one NR1 subunit and one or more modulatory subunits from the NR2 (NR2A-NR2D) and/or NR3 (NR3A, NR3B) families. Further eight splice variants have been identified for the NR1 subunits. Each functional NMDA receptor is a heteromultimer, consisting of combinations of NR1, NR2 and/or NR3 subunits. [Pg.45]

Levels of both glycine and D-serine are reported to be reduced in schizophrenia, although findings remain controversial. In the case of glycine, reduced plasma levels in schizophrenia correlate with the severity of negative symptoms (Sumiyoshi et al., 2004 Neeman et al., 2005) and response to clozapine (Sumiyoshi et al., 2005). In the case of D-serine, reduced serum (Hashimoto et al., 2003) and CSF (Hashimoto et al., 2005 Bendikov et al., 2007) levels have been reported, although contrary results have also been obtained (Fuchs et al., 2008). [Pg.46]

Moreover, if AMPA density falls below a critical threshold, levels of depolarization are insufficient to unblock NMDA channels, preventing postsynaptic depolarization or Ca2+ influx. The lack of Ca2+ influx prevents subsequent AMPA receptor insertion into the postsynaptic membrane. Thus, such synapses, despite containing intact NMDA receptors, are functionally silent and cannot be recovered by electrical stimulation alone (Isaac et al., 1999). This silencing of synapses could limit the degree of recovery to be expected even if normal glutamatergic functioning could be restored. [Pg.47]


In addition to halopeiidol, the putative neuroleptics, limcazole (311), lemoxipiide (312), and gevotioline (313) bind to (7-ieceptois as does the dopamine uptake blocker, GBR 12909 (314) and two ligands active at the NMDA receptor, ifenprodil (315) and CNS 1102 (316). NPC 16377, (317) is a selective (7-teceptor ligand. MAO inhibitors and antidepressants also bind to (7-teceptors. Some evidence indicates that (7-teceptors in the brain are in fact a form of cytochrome which may account for the diversity of ligands interacting with (7-sites. [Pg.573]

Grb-2 facilitates the transduction of an extracellular stimulus to an intracellular signaling pathway, (b) The adaptor protein PSD-95 associates through one of its three PDZ domains with the N-methyl-D-aspartic acid (NMDA) receptor. Another PDZ domain associates with a PDZ domain from neuronal nitric oxide synthase (nNOS). Through its interaction with PSD-95, nNOS is localized to the NMDA receptor. Stimulation by glutamate induces an influx of calcium, which activates nNOS, resulting in the production of nitric oxide. [Pg.16]

Antidepressants are used in the treatment of neuropathic pain and headache. They include the classic tricyclic compounds and are divided into nonselective nor-adrenaline/5-HT reuptake inhibitors (e.g., amitriptyline, imipramine, clomipramine, venlafaxine), preferential noradrenaline reuptake inhibitors (e.g., desipramine, nortriptyline) and selective 5-HT reuptake inhibitors (e.g., citalopram, paroxetine, fluoxetine). The reuptake block leads to a stimulation of endogenous monoaminer-gic pain inhibition in the spinal cord and brain. In addition, tricyclics have NMDA receptor antagonist, endogenous opioid enhancing, Na+ channel blocking, and K+ channel opening effects which can suppress peripheral and central sensitization. Block of cardiac ion channels by tricyclics can lead to life-threatening arrhythmias. The selective 5-HT transporter inhibitors have a different side effect profile and are safer in cases of overdose [3]. [Pg.77]

Lovinger DM (2000) Examination of ethanol spermine and acamprosate actions on native and recombinant NMDA receptors. Alcohol Clin Exp Res 24 183A... [Pg.486]

Whereas the role of AMPA and NMDA receptors in fast synaptic transmission is well characterized, only few examples demonstrating synaptic responses due to kainate receptor activation are known so far. [Pg.658]

Both AMPA and NMDA receptors are multimeric, probably tetrameric, assemblies of various molecularly distinct subunits, giving rise to large receptor diversity. For AMPA receptors this is achieved by assembling the... [Pg.658]

In contrast to AMPA receptors, NMDA receptor channels display a prominent Ca2+ permeability, which is largely independent ofthe subunit composition. It has been shown by mutational analysis that the Ca2+ permeability of recombinant NMDA receptors is dependent on a residue at a position equivalent to the Q/R site of AMPA subunits. Both NR1 and NR2 subunits contain an asparagine (N) residue at this position. Replacing this N with an R within the NR1 subunit led to the formation of NMDA receptors with a strongly reduced Ca2+ permeability, whereas exchanging N for Q in the NR2 subunit had only a small effect,... [Pg.659]

Antagonists selective for kainate receptors are not available yet. The non-NMDA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) blocks AMPA as well as kainate receptors. Nevertheless, compounds like GYKI53655, which acts as a noncompetitive antagonist of AMPA receptors and completely blocks AMPA receptor function at certain concentrations at which no antagonistic effect on kainate receptors is discernible, has been used to demonstrate the kainate receptor-mediated currents in neurons. [Pg.661]

Kemp JA, Kew JNC, Gill R (1999) NMDA receptor antagonists and their potential as neuroprotective agents, chapter 16 Ionotropic glutamate receptors in the CNS. Springer Verlag... [Pg.661]

Lipton SA (2006) Paradigm shift in neuroprotection by NMDA receptor blockade memantine and beyond. Nat Rev Drug Discov 5 160-170... [Pg.661]

NMDA (iV-methyl-D-aspartic acid) is a synthetic derivative of aspartic acid and represents the prototypical agonist at the NMDA receptors for which the latter were named. [Pg.861]

NMDA receptors are subtypes of ionotropic glutamate receptors activated by NMDA forming heteromers... [Pg.861]

On the pathophysiological side, hyperactive nNOS has been implicated in A/-methyl-D-aspartate (NMDA)-receptor-mediated neuronal death in cerebrovascular-stroke. Some disturbances of smooth muscle tone within the gastrointestinal tract (e.g., gastroesophageal reflux disease) may also be related to an overproduction of NO by nNOS in peripheral nitrergic nerves. [Pg.863]


See other pages where NMDA receptors, 50-51 is mentioned: [Pg.551]    [Pg.325]    [Pg.73]    [Pg.75]    [Pg.76]    [Pg.77]    [Pg.130]    [Pg.484]    [Pg.534]    [Pg.552]    [Pg.553]    [Pg.658]    [Pg.658]    [Pg.658]    [Pg.658]    [Pg.659]    [Pg.659]    [Pg.660]    [Pg.660]    [Pg.660]    [Pg.660]    [Pg.662]    [Pg.678]    [Pg.760]    [Pg.762]    [Pg.837]    [Pg.838]    [Pg.853]    [Pg.858]    [Pg.858]    [Pg.861]    [Pg.928]    [Pg.931]    [Pg.1045]    [Pg.1046]    [Pg.1046]    [Pg.1498]    [Pg.204]   
See also in sourсe #XX -- [ Pg.222 , Pg.317 , Pg.381 , Pg.420 ]

See also in sourсe #XX -- [ Pg.489 , Pg.515 ]

See also in sourсe #XX -- [ Pg.6 , Pg.26 , Pg.69 ]

See also in sourсe #XX -- [ Pg.34 ]

See also in sourсe #XX -- [ Pg.22 , Pg.84 , Pg.100 ]

See also in sourсe #XX -- [ Pg.9 ]

See also in sourсe #XX -- [ Pg.241 , Pg.242 , Pg.243 ]

See also in sourсe #XX -- [ Pg.266 , Pg.269 , Pg.289 , Pg.389 , Pg.390 , Pg.392 , Pg.393 , Pg.394 , Pg.396 , Pg.401 , Pg.402 , Pg.429 , Pg.499 ]

See also in sourсe #XX -- [ Pg.1786 , Pg.1787 , Pg.1903 ]

See also in sourсe #XX -- [ Pg.22 , Pg.23 ]

See also in sourсe #XX -- [ Pg.493 ]

See also in sourсe #XX -- [ Pg.58 , Pg.59 , Pg.75 ]

See also in sourсe #XX -- [ Pg.78 , Pg.254 ]

See also in sourсe #XX -- [ Pg.112 , Pg.113 , Pg.118 , Pg.119 , Pg.124 , Pg.125 , Pg.137 , Pg.138 , Pg.147 , Pg.183 , Pg.193 , Pg.200 ]

See also in sourсe #XX -- [ Pg.366 , Pg.367 , Pg.744 , Pg.757 ]

See also in sourсe #XX -- [ Pg.164 , Pg.311 ]

See also in sourсe #XX -- [ Pg.164 , Pg.311 ]

See also in sourсe #XX -- [ Pg.241 , Pg.242 , Pg.243 ]

See also in sourсe #XX -- [ Pg.164 , Pg.311 ]

See also in sourсe #XX -- [ Pg.2 , Pg.386 ]

See also in sourсe #XX -- [ Pg.64 ]

See also in sourсe #XX -- [ Pg.64 ]

See also in sourсe #XX -- [ Pg.99 , Pg.104 ]

See also in sourсe #XX -- [ Pg.241 , Pg.242 , Pg.258 ]

See also in sourсe #XX -- [ Pg.1051 , Pg.1062 , Pg.1070 , Pg.1160 , Pg.1210 ]

See also in sourсe #XX -- [ Pg.25 , Pg.25 ]

See also in sourсe #XX -- [ Pg.386 ]

See also in sourсe #XX -- [ Pg.352 , Pg.432 , Pg.446 , Pg.454 , Pg.511 , Pg.517 , Pg.523 ]

See also in sourсe #XX -- [ Pg.198 , Pg.199 ]

See also in sourсe #XX -- [ Pg.449 , Pg.450 ]

See also in sourсe #XX -- [ Pg.34 ]

See also in sourсe #XX -- [ Pg.118 ]




SEARCH



Anticonvulsants NMDA receptor antagonists

Antinociception action via glutamate NMDA receptor

Barbiturates NMDA receptors

Brain NMDA receptor subunits

Brain NMDA receptors

Calcium NMDA receptor activation

Cognitive enhancers NMDA receptors

Development NMDA receptors

Excitotoxicity NMDA receptor antagonists

Excitotoxicity NMDA receptors

Glutamate receptor competitive NMDA

Glutamate receptor noncompetitive NMDA

Glutamate receptors NMDA receptor subunits

Glutamate receptors, NMDA-type

Glycine NMDA receptors

Granule cells NMDA receptors

Hippocampal NMDA receptors

Ketamine, NMDA receptor antagonism

Magnesium NMDA receptor antagonist

Memory NMDA receptor

Methadone NMDA receptor antagonist

NMDA

NMDA Receptor Glycine-site Agonists

NMDA glutamate receptor

NMDA receptor antagonists

NMDA receptor antagonists Huntington disease

NMDA receptor antagonists Subject

NMDA receptor antagonists amantadine

NMDA receptor antagonists analgesics

NMDA receptor antagonists antagonist memantine

NMDA receptor antagonists antidepressants

NMDA receptor antagonists chronic pain

NMDA receptor antagonists dextromethorphan

NMDA receptor antagonists efficacy

NMDA receptor antagonists ketamine

NMDA receptor antagonists memantine

NMDA receptor antagonists neramexane

NMDA receptor gene expression in hippocampal principal cells

NMDA receptor subunit mRNA distribution in the caudate putamen

NMDA receptor subunit mRNAs in the lumbar spinal cord

NMDA receptor subunit mRNAs in the neocortex

NMDA receptor system

NMDA receptor-mediated responses

NMDA receptors activation

NMDA receptors alcohol

NMDA receptors anchoring

NMDA receptors anesthetics

NMDA receptors antidepressants

NMDA receptors antiepileptics

NMDA receptors antipsychotic action

NMDA receptors cerebellum

NMDA receptors classification

NMDA receptors clinical pharmacology

NMDA receptors competitive antagonists

NMDA receptors domain

NMDA receptors effects

NMDA receptors ethanol affecting

NMDA receptors function

NMDA receptors gating

NMDA receptors gene studies

NMDA receptors hippocampal, function

NMDA receptors hippocampus

NMDA receptors hypoxia

NMDA receptors ketamine

NMDA receptors mRNA distribution

NMDA receptors neocortex

NMDA receptors neurotoxicity

NMDA receptors noncompetitive antagonists

NMDA receptors phencyclidine

NMDA receptors phosphorylation, regulation

NMDA receptors physiological activity

NMDA receptors recognition sites

NMDA receptors retina

NMDA receptors spinal cord

NMDA receptors splice variants

NMDA receptors stimulation

NMDA receptors stroke

NMDA receptors structures

NMDA receptors subunits

NMDA receptors therapeutic potential

NMDA receptors toxicity

NMDA receptors, agonists

NMDA-induced currents receptors

Neuroprotective Effects of NMDA Receptors

Non-NMDA receptors

Other interactions of NMDA receptors

Polyamines, NMDA receptors

Purkinje cells NMDA receptor subunits

Retinal NMDA receptors

Riluzole NMDA receptor antagonist

Schizophrenia NMDA receptor

Schizophrenia NMDA receptor antagonists

Schizophrenia NMDA receptor hypofunction

Synapic potential mediation by non-NMDA receptors

Synaptic modulation NMDA receptors

The NMDA Receptor

Tyrosine NMDA receptors

© 2024 chempedia.info